Novo Nordisk A/S (NVO) — chart, structure and Closelook read

Pick a ticker to load its detail page.

Signals for this name

Every Closelook reading that exists for NVO, from the same nightly bakes the boards use. Research diary readings, not advice.

GLP-1 leaders, gene-editing platforms, diagnostics-at-scale, biopharma compounders. Demographics writes the demand curve.

Compared against NVO on the nightly bakes; the Peers tab ranks the cohort on the Closelook scores where it exists.

The weather around this name

Macro readings that apply by membership — the regime, the factor tape, the sector cell, the funding backdrop.

About Novo Nordisk A/S

Novo Nordisk A/S (NVO) trades on US exchanges in Denmark, classified under Healthcare. It is a constituent of HALO Growth 100.

The Closelook company score reads 55/100 composite (momentum 46, quality 85, valuation 73) across 7 modules — the full three-layer breakdown, chart structure and analog history load live above.

closelook.net is an investment research diary — market structure, index membership and scores are our own readings, not investment advice. Related: index compare · sector dispersion · scanner.

FAQ · from the current data · as of 2026-09-15

Quick answers

What is Novo Nordisk A/S (NVO)?

Novo Nordisk A/S trades as NVO on the US exchange (Denmark) and is classified under Healthcare in the Closelook research universe, as of the registry build of 2026-09-15.

Is NVO in a Closelook index?

Yes — Novo Nordisk A/S is a constituent of HALO Growth 100, as of 2026-09-15.

What is Novo Nordisk A/S's Closelook composite score?

55 out of 100, with momentum 46, quality 85 and valuation 73 sub-scores, as of 2026-09-15. Scores are Closelook's own research readings, not ratings or investment advice.

What does this page show?

A live price chart with SMA overlays and drawing tools for NVO, performance metrics, index-membership context and the Closelook structure read — an investment research diary view, not investment advice.

Related in the Closelook universe